BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2404676)

  • 1. Lymphadenosis benigna cutis versus primary cutaneous B-cell lymphomas of follicular center cell origin.
    Rijlaarsdam JU; Meijer CJ; Willemze R
    Curr Probl Dermatol; 1990; 19():189-95. PubMed ID: 2404676
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
    Evans HL; Winkelmann RK; Banks PM
    Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. A comparative clinicopathologic study of 57 patients.
    Rijlaarsdam JU; Meijer CJ; Willemze R
    Cancer; 1990 May; 65(10):2301-6. PubMed ID: 2346914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytoma of the skin simulating lymphadenosis benigna cutis.
    van der Putte SC; Toonstra J; Schuurman HJ; van Unnik JA
    Arch Dermatol Res; 1985; 277(1):36-43. PubMed ID: 3918512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Kerl H
    Semin Cutan Med Surg; 1999 Mar; 18(1):64-70. PubMed ID: 10188844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonclonal lymphocytic proliferation in cutaneous lymphoid hyperplasia: a flow-cytometric and morphological analysis.
    Fan K; Kelly R; Kendrick V
    Dermatology; 1992; 185(2):113-9. PubMed ID: 1421622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders.
    Cerroni L; Kerl H
    Dermatol Clin; 1994 Apr; 12(2):219-29. PubMed ID: 8045034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
    Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenosis benigna cutis.
    Bäfverstedt B
    Acta Derm Venereol; 1968; 48(1):1-6. PubMed ID: 4174099
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies].
    Burg G
    Fortschr Med; 1976 Jun; 94(18):1089-98. PubMed ID: 1085739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extra-lymphnodal pseudolymphoma].
    Eusebi V; Giangaspero F; Bondi A
    Recenti Prog Med; 1979 Aug; 67(2):267-87. PubMed ID: 388554
    [No Abstract]   [Full Text] [Related]  

  • 12. The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis).
    Schmoeckel C; Burg G; Wolf HH; Braun-Falco O
    Arch Dermatol Res (1975); 1977 Apr; 258(2):161-7. PubMed ID: 869578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant lymphomas of the skin: their differentiation from lymphoid and nonlymphoid cutaneous infiltrates that simulate lymphoma.
    Burke JS
    Semin Diagn Pathol; 1985 Aug; 2(3):169-82. PubMed ID: 3916553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MT2 and anti-bcl-2 protein antibodies in the differentiation of benign from malignant cutaneous infiltrates of B-lymphocytes with germinal center formation.
    Chimenti S; Cerroni L; Zenahlik P; Peris K; Kerl H
    J Cutan Pathol; 1996 Aug; 23(4):319-22. PubMed ID: 8864918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of T & B lymphocytes on skin sections from patients with lymphoproliferative disorders of the skin.
    David M; Shohat B; Hazaz B; Feuerman EJ; Joshua H
    J Invest Dermatol; 1980 Dec; 75(6):491-4. PubMed ID: 7003028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous lymphomas.
    Seçkin D; Hofbauer GF
    Cancer Treat Res; 2009; 146():343-51. PubMed ID: 19415215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Angiocentric cutaneous lymphoproliferative disorders].
    Bachelez H
    Ann Dermatol Venereol; 2000 Jan; 127(1):97-100. PubMed ID: 10717574
    [No Abstract]   [Full Text] [Related]  

  • 18. Nodular lymphoid disease of the head and neck: lymphocytoma cutis, benign lymphocytic infiltrate of Jessner, and their distinction from malignant lymphoma.
    Van Hale HM; Winkelmann RK
    J Am Acad Dermatol; 1985 Mar; 12(3):455-61. PubMed ID: 3872891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic difficulties in 'non-mycotic' cutaneous lymphoproliferative diseases.
    Slater DN
    Histopathology; 1992 Sep; 21(3):203-13. PubMed ID: 1398519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T lymphocytes in lymphoproliferative diseases of the skin. Effect of a thymic hormone on the immunocompetence of T lymphocytes.
    David M; Shohat B; Trainin N; Feuerman EJ
    Br J Dermatol; 1980 Feb; 102(2):145-8. PubMed ID: 6966933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.